SeaStar Medical Holding (ICU) Net Cash Flow (2021 - 2026)

SeaStar Medical Holding (ICU) has reported Net Cash Flow for 6 consecutive years, with -$2.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Cash Flow fell 337.48% year-over-year to -$2.4 million; the trailing twelve-month figure through Jun 2026 stood at $657000.0 (down 87.18% YoY), and the FY2025 full-year result was $10.2 million, up 518.44% from the prior year.
• Net Cash Flow climbed to -$2.4 million in Q2 2026 per ICU's latest filing, from -$2.6 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $7.5 million in Q3 2025 and bottomed at -$3.8 million in Q2 2024.
• Historically, Net Cash Flow has averaged $358277.8 across 5 years, with a median of $29000.0 in 2022.
• The sharpest annual moves came in 2023 and 2025: Net Cash Flow soared 5250.0% in 2023, then tumbled 577.95% in 2025.
• Over 5 years, Net Cash Flow stood at -$2000.0 in 2022, then jumped by 5250.0% to $103000.0 in 2023, then slumped by 355.34% to -$263000.0 in 2024, then sank by 577.95% to -$1.8 million in 2025, then plunged by 33.99% to -$2.4 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$2.4 million, -$2.6 million, and -$1.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.